Condition: Rare Diseases · Fabry Disease · Fabry Disease, Cardiac Variant · Sponsor: Wuerzburg University Hospital
This study evaluates predictors for the incidence of arrhythmias and sudden cardiac death as well as terminal heart failure in patients with Fabry disease.
This description comes directly from the study's public registry record.
Peter Nordbeck, MD, PhD · 004993120139181 · nordbeck_p@ukw.de
Jonas Muentze, MD · 004993120139958 · muentze_j@ukw.de
Always discuss trial participation with your own doctor first.
| Wuerzburg University Hospital | Würzburg, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03362164